# Amylyx Pharmaceuticals (stock symbol: AMLX) Logo in transparent PNG and SVG formats

## Amylyx Pharmaceuticals Logo large

### Amylyx Pharmaceuticals Logo large Download PNG (23.3 KB)

![Amylyx Pharmaceuticals Logo large Download PNG (23.3 KB)](/img/orig/AMLX_BIG-b7ebc11c.png)

### Amylyx Pharmaceuticals Logo large Download SVG (7.85 KB)

![Amylyx Pharmaceuticals Logo large Download SVG (7.85 KB)](/img/orig/AMLX_BIG-e772a75e.svg)

## Amylyx Pharmaceuticals Logo icon format

### Amylyx Pharmaceuticals Logo icon format Download PNG (30.64 KB)

![Amylyx Pharmaceuticals Logo icon format Download PNG (30.64 KB)](/img/orig/AMLX-ec99a902.png)

### Amylyx Pharmaceuticals Logo icon format Download SVG (3.03 KB)

![Amylyx Pharmaceuticals Logo icon format Download SVG (3.03 KB)](/img/orig/AMLX-1f9bd909.svg)

## Amylyx Pharmaceuticals Logo large for dark backgrounds

### Amylyx Pharmaceuticals Logo large for dark backgrounds Download PNG (23.31 KB)

![Amylyx Pharmaceuticals Logo large for dark backgrounds Download PNG (23.31 KB)](/img/orig/AMLX_BIG.D-72ee1564.png)

### Amylyx Pharmaceuticals Logo large for dark backgrounds Download SVG (7.47 KB)

![Amylyx Pharmaceuticals Logo large for dark backgrounds Download SVG (7.47 KB)](/img/orig/AMLX_BIG.D-716b5bf0.svg)

## Amylyx Pharmaceuticals Logo icon format for dark backgrounds

### Amylyx Pharmaceuticals Logo icon format for dark backgrounds Download PNG (30.64 KB)

![Amylyx Pharmaceuticals Logo icon format for dark backgrounds Download PNG (30.64 KB)](/img/orig/AMLX.D-a85357e4.png)

### Amylyx Pharmaceuticals Logo icon format for dark backgrounds Download SVG (3.03 KB)

![Amylyx Pharmaceuticals Logo icon format for dark backgrounds Download SVG (3.03 KB)](/img/orig/AMLX.D-1eb713bd.svg)

## About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

1. Website domain: amylyx.com
2. Employees: 226
3. Marketcap: $1.89 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
